• RESPOND™ fosters global partnerships between clinical academic centers, the health care industry, and government & private agencies to better utilize and understand naturally occurring disease in animals in order to improve veterinary and human health.
• RESPOND™ gathers history, clinical signs, laboratory data, treatment regimens, risk factors and response to therapy from owners and veterinarians throughout the world.
• RESPOND™ will serve as a valuable resource for the medical community for the development of new diagnostic tests, procedures, and treatment modalities.
• RESPOND™ fosters national & international research into spontaneous disease of animals and promotes evidence-based medicine in veterinary practice.
• RESPOND™ promotes the use of animals with spontaneous disease for proof-of-concept (pre-clinical) trials where these diseases have a corollary with human disease.

• RESPOND™ is a global, comprehensive source of information on the prevalence of spontaneous disease and the efficacy of various treatments in veterinary patients that is missing from most current veterinary disease registries.
• RESPOND™ is an inexpensive, authenticated source of information on spontaneous diseases that is missing from current disease registries.
• RESPOND™ provides sufficient clinical detail to develop new treatment methods and allow outcomes assessment and risk/benefit analysis.

• Access to Data: Data from RESPOND™ is available to registered users with permission of the Scientific Advisory Board. Procedures to protect the confidentiality of data and the interests and intellectual property of all users have been implemented.
• Data Analysis: Statisticians, epidemiologists, and health science researchers have access to RESPOND™ information for high-quality data analysis and publications.
• Data Collection: Data collection procedures have been simplified to minimize the work load & need for individual training of RESPOND™ participants.

RESPOND™ data collection is facilitated by using a simple, structured, web-based database that:

• allows data organization to be modified as new questions arise
• is based on planned analyses and has been implemented and tested on a manageable subset of patients before being expanded

• Clinical academic centers, veterinary specialty groups, veterinary specialty practices, and private veterinary practices (a) collect accurate and complete data on all eligible patients, (b) give input as to important clinical questions, and (c) contribute to data publication.
• Government agencies (a) support registry workshops and meetings, (b) provide analytic expertise and resources, (c) contribute to reports and publications, (d) assist with links to other databases, and (e) disseminate data.
• Non-governmental agencies (a) promote the registry to constituents, (b) participate in workshops and meetings, (c) give access to peer review, and (d) disseminate data.
• Industrial partners contribute (a) financial support, (b) intellectual input on drugs, tests, devices, (c) give input as to important questions to ask, and (d) assist with data publication.